<DOC>
	<DOCNO>NCT02937831</DOCNO>
	<brief_summary>The purpose survey understand follow item observe actual clinical use RIXUBIS . 1 . Unexpected adverse drug reaction 2 . Occurrence adverse drug reaction actual clinical use 3 . Factors may affect safety effectiveness 4 . Occurrence Factor IX ( FIX ) inhibitor development patient coagulation FIX deficiency 5 . Safety effectiveness hemophilia B patient receive routine prophylactic therapy , on-demand therapy perioperative therapy</brief_summary>
	<brief_title>RIXUBIS Drug Use-Result Survey ( Japan )</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia B</mesh_term>
	<criteria>Patients hemophilia B schedule receive treatment RIXUBIS Patients administer RIXUBIS</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>